Businesses that produce bioscience products - gene tests and therapies, pharmaceuticals, vaccines and medical devices - are constantly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work. This book follows industry research, development and the marketing of medical and bioscience products across a variety of fields, including biotechnology, pharmaceuticals and bio-agriculture. Compelling and current case studies highlight the ethical decisions business managers frequently face. With the increasing visibility and public expectation placed on businesses in this sector, managers need to understand the ethical and social issues. This book addresses that need and provides a framework for incorporating ethical analysis in business decision making.
Businesses that produce bioscience products - gene tests and therapies, pharmaceuticals, vaccines and medical devices - are constantly confronted with ethical issues concerning these technologies. Conflicts exist between those who support advancements in bioscience and those who fear the consequences of unfettered scientific license. As the debate surrounding bioscience grows, it will be increasingly important for business managers to consider the larger consequences of their work. This book follows industry research, development and the marketing of medical and bioscience products across a variety of fields, including biotechnology, pharmaceuticals and bio-agriculture. Compelling and current case studies highlight the ethical decisions business managers frequently face. With the increasing visibility and public expectation placed on businesses in this sector, managers need to understand the ethical and social issues. This book addresses that need and provides a framework for incorporating ethical analysis in business decision making.
Table of Contents for Politics Beyond the Capital List of Tables Acknowledgments Part One: Introduction 1. Explaining Decentralization of Re-centralization 2. Definitions, Cases, Patterns Part Two: Nineteenth-Century Origins, Twentieth-Century Trajectories 3. Decentralization from Below: Argentina before 1966, Brazil before 1964 4. Decentralization from Above: Chile and Uruguay before 1973 Part Three: Bureaucratic Authoritarianism Beyond the Capital 5. Subnational Reforms by Military Governments Part Four: Subnational Institutions in the Third Wave of Democracy 6. Reemergence of the Governors in Argentina and Brazil 7. National Engineering of Subnational Institutions in Chile and Uruguay Part Five: Conclusion 8.A Comparing Waves and Approaches Notes Works Cited Index
Margaret L. Eaton is a Senior Research Scholar at the Stanford Center for Biomedical Ethics and a Lecturer in the Stanford Graduate School of Business. She is a founding member of the Bioscience Business Ethics Center, Keck Graduate Institute, Claremont Colleges.
"The stakes in bioscience, both moral and financial, are high. While each of the landmark cases depicted in Ethics and the Business of Bioscience offers distinct lessons, in aggregate it becomes clear that those engaged in bioscience and business must learn to exercise moral reasoning as scientific adn financial decisions are being made. Eaton's accessible text should prove to be a useful resource for those learning to do so." --Journal of the American Medical Association
 |
Ask a Question About this Product More... |
|
